BIOVINTIS PHARMA PRIVATE LIMITED

CIN U21001DL2026PTC462949

Private Limited CompanyIncorporated 4 February 2026

BIOVINTIS PHARMA PRIVATE LIMITED is a private limited company incorporated on 4 February 2026 with the Registrar of Companies, Delhi. Its CIN is U21001DL2026PTC462949 and it is registered in New Delhi, Delhi. Its main business activity is manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc. (NIC 21001). It has an authorised capital of ₹15,00,000 and a paid-up capital of ₹1,00,000. Its directors are RAJESH KUMAR SINGH, NEELAM and NAWNEET KUMAR RAI.

Company details

Name
BIOVINTIS PHARMA PRIVATE LIMITED
CIN
U21001DL2026PTC462949
Type
Private Limited Company
Date of incorporation
4 February 2026
Registrar of Companies
ROC Delhi
Category
Company limited by shares
Sub-category
Non-government company
Authorised capital
₹15,00,000
Paid-up capital
₹1,00,000
Business activity
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.
NIC code
21001
State
Delhi
District
New Delhi

Registered office: H.No-248 & 249 3rd Floor, LeftSideBlockBMohanGarden, New Delhi, Delhi, 110059

Directors

  • RAJESH KUMAR SINGHDirector
  • NEELAMDirector
  • NAWNEET KUMAR RAIDirector

First-year compliance calendar

Due dates worked out from the incorporation date. Check the latest MCA notifications for extensions.

ComplianceDue
First board meetingwithin 30 days of incorporation6 March 2026
Appoint the first auditorby the board, within 30 days6 March 2026
Issue share certificateswithin 60 days of incorporation5 April 2026
Commencement of business (INC-20A)within 180 days, after subscribers pay for their shares3 August 2026
Director KYC (DIR-3 KYC)every year, for each director's DIN30 September 2026
Financial statements (AOC-4) and annual return (MGT-7A / MGT-7)AGM due by 31 December 2026; AOC-4 within 30 days and MGT-7 within 60 days of itafter the first AGM

What the CIN U21001DL2026PTC462949 means

U — listing
Unlisted
21001 — industry (NIC)
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.
DL — state / ROC code
Delhi
2026 — year of incorporation
2026
PTC — ownership
Private Limited Company
462949 — registration number
Serial number at the ROC

Never miss an ROC deadline for your clients

Finexo's practice management software tracks INC-20A, AOC-4, MGT-7, LLP Form 8 and Form 11 for every client company, assigns the work to your team and reminds clients before the due date.

See Finexo for CA firms

More new companies in New Delhi

More companies and LLPs

Is this your CIN?

Search another company

Details from Ministry of Corporate Affairs records, last updated 12 October 2026.